The Genetic Age promises another exponential increase in human knowledge and potential. ... This article describes three frameworks the law uses to regulate genetic technology: (1) Individual Rights and Duties; (2) Scientific Regulation by Administrative Agencies; and (3) Legislative Preemption. ... This framework involves the lowest level of government oversight over genetic technology. ... At present, the FDA and National Institutes of Health (NIH) administer regulatory control of genetic technology as applied to human beings, but the jurisdiction of these agencies is limited. ... Attorney Judith Cregan has recorded a number of serious problems with FDA and NIH regulation of human gene therapy, including concerns about patient safety, ...
Thanks to rapid advances in genetic technology, scientists can give cells cancer-fighting capabiliti...
The idea that genetic information is different from other medical information and therefore needs sp...
This Article is one of the first to analyze the effect of the 23andMe Warning Letter on the industry...
Genetic enhancement technologies present difficult and novel regulatory issues, including the proble...
Over the past ten years scientists have perfected revolutionary techniques in the field of genetic e...
This article considers the scientific, legal, ethical, and social issues of the Brave New World of B...
Continuing advances in the science of molecular genetics have produced technologies that are capable...
The article is ah attempt to present some chosen kinds of problems involved with genetic engineerin...
The biotechnological field of genetic engineering is advancing so rapidly that some scientists predi...
This article examines the intersection of patent law, FDA regulation, and Medicare coverage in a par...
Human genetic resources are increasingly considered as ordinary commercial goods, but their value an...
In a 1980 landmark decision, the Supreme Court of the United States ruled that genetically engineere...
This article examines the intersection of patent law, FDA regulation, and Medicare coverage in a par...
In its broadest sense, referring to the application of a biological process to provide a good or ser...
Over the past few years, there have been some dramatic developments in intellectual property (IP) an...
Thanks to rapid advances in genetic technology, scientists can give cells cancer-fighting capabiliti...
The idea that genetic information is different from other medical information and therefore needs sp...
This Article is one of the first to analyze the effect of the 23andMe Warning Letter on the industry...
Genetic enhancement technologies present difficult and novel regulatory issues, including the proble...
Over the past ten years scientists have perfected revolutionary techniques in the field of genetic e...
This article considers the scientific, legal, ethical, and social issues of the Brave New World of B...
Continuing advances in the science of molecular genetics have produced technologies that are capable...
The article is ah attempt to present some chosen kinds of problems involved with genetic engineerin...
The biotechnological field of genetic engineering is advancing so rapidly that some scientists predi...
This article examines the intersection of patent law, FDA regulation, and Medicare coverage in a par...
Human genetic resources are increasingly considered as ordinary commercial goods, but their value an...
In a 1980 landmark decision, the Supreme Court of the United States ruled that genetically engineere...
This article examines the intersection of patent law, FDA regulation, and Medicare coverage in a par...
In its broadest sense, referring to the application of a biological process to provide a good or ser...
Over the past few years, there have been some dramatic developments in intellectual property (IP) an...
Thanks to rapid advances in genetic technology, scientists can give cells cancer-fighting capabiliti...
The idea that genetic information is different from other medical information and therefore needs sp...
This Article is one of the first to analyze the effect of the 23andMe Warning Letter on the industry...